TechnipFMC plc financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data TechnipFMC plc files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	9,200	15,057	12,553	6,950	6,531	6,404	6,700	7,824	9,083	9,933
Cost of revenue	0	2,403					5,793	6,541	7,362
Gross profit	9,200	12,654					907	1,283	1,722
Research and development	105	213	189	150	75.3	78.4	67	69	73.4	83.1
Selling, general and administrative	573	1,061	1,141	796	724	645	617	676	667	705
Operating income	766	1,354	-533	-2,105	-3,245	183	376	658	1,157	1,436
Interest expense	114	456	482	135	134	157	139	122	97.4	81.4
Interest income	85.3	141	121	43.6	52.3	14	17.8	33.5	33.9	41.9
Other non-operating income	6.5	-25.9	-324	-182	25.1	46.6	5.4	-248	-45.9	-57.7
Pre-tax income	551	680	-1,488	-2,571	-3,499	198	68.9	207	940	1,270
Income tax	180	546	423	79	19.4	111	105	155	85.1	303
Income from continuing operations	393	113		-2,646	-3,553	87.8	-61.9	56.2	843	964
Net income to minority interests	-22.2	20.9	10.8	3.1	49.7
Net income	393	113	-1,922	-2,415	-3,288	13.3	-107	56.2	843	964
EBITDA	1,067	1,969	17.7	-1,638	-2,833	569	753	1,036	1,550	1,878
EPS, basic	3.29	0.24	-4.20	-5.39	-7.33	0.03	-0.24	0.13	1.96	2.34
EPS, diluted	3.16	0.24	-4.20	-5.39	-7.33	0.03	-0.24	0.12	1.91	2.30
Shares, basic (weighted)	119	467	458	448	449	451	450	439	429	412
Shares, diluted (weighted)	125	448	458	448	449	455	450	452	441	420
Dividend per share		0.13	0.52	0.52	0.13			0.20	0.20	0.20

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	6,269	6,737	5,540	1,563	1,269	1,327	1,057	952	1,158	1,032
Receivables	1,470	1,484	2,470	2,287	40.6	21.9	12.4	9.1	8.1	8.1
Inventory	335	987	1,251	1,416	1,253	1,032	1,040	1,100	1,077	1,153
Other current assets	799	1,206	656	864	683	512	455	414	463	545
Total current assets	10,937	12,977	11,781	11,886	11,445	5,342	4,989	5,195	5,468	5,545
Property, plant and equipment	2,620	3,872	3,260	3,162	2,756	2,597	2,355	2,271	2,134	2,285
Lease right-of-use assets			0	893	785	708	802	740	723	774
Goodwill	3,718	8,930	7,608	3,129	2,513
Intangible assets	174	1,334	1,177	1,087	851	814	716	602	508	426
Other non-current assets	250	329	314	293	176	130	127	288	258	340
Total assets	18,679	28,264	24,785	23,519	19,693	10,020	9,444	9,657	9,869	10,118
Accounts payable	3,838	3,959	2,600	2,660	1,201	1,294	1,283	1,356	1,303	1,180
Accrued liabilities	308	402	395	412	187	194	176	188	185
Deferred revenue	411	3,314	4,085	4,585	1,047	1,013	1,156	1,486	1,787	2,149
Short-term debt	684	77.1	67.4	495	625	278	367	154	278	34.3
Total current liabilities	10,889	9,829	9,139	10,138	10,415	3,852	4,174	4,469	4,865	4,915
Long-term debt	1,869	3,778	4,124	3,980	2,836	1,727	999	914	607	396
Lease liabilities			0	682	633	647	736	667	662	674
Other non-current liabilities	358	477	540	430	103	148	138	146	119	364
Total liabilities	13,677	14,854	14,357	15,790	15,435	6,602	6,168	6,485	6,731	6,713
Total debt	2,553	3,855	4,192	4,475	3,460	2,005	1,367	1,067	885	430
Paid-in capital	2,683	10,483	10,197	10,183	10,242	9,161	9,110	8,939	8,653	8,082
Retained earnings	3,404	3,448	1,072	-1,563	-4,915	-4,904	-5,010	-4,993	-4,310	-3,761
Treasury stock	-44.5	0
Other comprehensive income	-1,102	-1,004	-1,360	-1,408	-1,623	-1,305	-1,302	-1,242	-1,673	-1,357
Shareholders' equity	5,056	13,388	10,358	7,659	4,154	3,403	3,240	3,137	3,094	3,364
Minority interests	-11.7	21.5	31.3	28.8	60.1	15.7	36.5	35.4	44.6	41.5
Total equity	5,002	13,367	10,389	7,688	4,214	3,418	3,277	3,172	3,138	3,405
Total liabilities and equity	18,679	28,264	24,785	23,519	19,693	10,020	9,444	9,657	9,869	10,118
Shares outstanding	119	465	451	447	450	451	442	433	423	401

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	371	134	-1,911	-2,412	-3,238	14.4	-81.8	51.9	855	967
Depreciation and amortization	301	615	550	468	412	385	377	378	393	442
Stock-based compensation	22	49.1	49.1	44.4	38.3	26.8	40.5	40.9	58.3	61.9
Deferred income tax	-172	142	48.8	27.9	-31.8	-95.1	-13	-54.2	-246	36
Change in receivables	-269	287	-664	-143	433	-73.1	-160	-228	-236	213
Change in inventory	173	131	-339	-173	87.4	198	-35	-91.2	-42	-23.3
Change in payables	116	-526	-1,249	-56.1	-236	93.8	52.1	62.5	8.2	-230
Cash from operations	494	211	-185	849	657	781	352	693	961	1,765
Capital expenditures	-313	-256	-368	-413	-256	-192	-158	-225	-282	-317
Acquisitions	0	0	-105
Purchases of investments		0	0	-71.6	-17.9
Sales and maturities of investments		0	0	18.9
Cash from investing	3,111	1,250	-460	-420	-181	817	162	-126	-75.8	-298
Debt issued	645	25.7		96.2	223	1,164	60.9	0	0
Debt repaid	-891	-888	0	0	-424	-1,462	-452	0	0
Stock issued			0	0	0	0	0	1.1	32.2	3.7
Share buybacks	-187	-58.5	-443	-92.7	0	0	-100	-205	-400	-918
Dividends paid	-112	-60.6	-238	-233	-59.2	0	0	-43.5	-85.9	-82.3
Cash from financing	-535	-1,055	-445	-784	-1,082	-5,065	-797	-657	-648	-1,621
Exchange rate effect	21.6	62.2	-107	5.9	224	-14
Net change in cash	3,091	468	-1,197	-350	-382	-3,480	-270	-105	206	-126
Free cash flow	181	-45	-554	436	401	590	194	468	679	1,447
Interest paid	40.2	50.3	99	91.5	96	104	109	93.4	63.1	55.6
Income taxes paid	261	425	411	104	108	25.1	189	151	250	359

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $70.99 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	16.0%	Operating income / revenue.
EBITDA margin	20.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	14.4%	Pre-tax income / revenue.
Net margin	11.3%	Net income / revenue.
FCF margin	15.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	17.8%	Cash from operations / revenue.
Effective tax rate	21.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	35.9%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	11.3%	Net income / average total assets.
Return on invested capital (ROIC)	48.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	0.9%	Research and development expense / revenue.
SG&A / revenue	7.0%	Selling, general and administrative expense / revenue.
Capex / revenue	2.8%	Capital expenditures / revenue.
D&A / revenue	4.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	9.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	14.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	8.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	24.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	56.3%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	21.2%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	35.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	14.4%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	20.4%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	83.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	71.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	21.9%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	113.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	95.3%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	29.3%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 5y	9.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	8.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	1.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-4.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	2.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	2.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-12.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-4.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.08x	Current assets / current liabilities.
Quick ratio	0.18x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.18x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.12x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	3.9%	Total debt / total assets.
Liabilities / assets	68.4%	Total liabilities / total assets.
Net debt	-$589.9M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.28x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	25.9x	Operating income / interest expense.
Working capital	$437.6M	Current assets - current liabilities.
Goodwill and intangibles / assets	3.7%	(Goodwill + intangible assets) / total assets.
Tangible book value	$2.89B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.00x	Revenue / average total assets.
Fixed asset turnover	4.62x	Revenue / average property, plant and equipment.
FCF conversion	133.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	15.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.91	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$25.76	Revenue / diluted weighted shares.
FCF per share	$3.89	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4.60	Cash from operations / diluted weighted shares.
Book value per share	$8.33	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$7.36	Tangible book value / shares outstanding.
Cash per share	$2.52	(Cash + short-term investments) / shares outstanding.
Payout ratio	6.8%	Dividends paid / net income, when net income is positive.
Dividends / FCF	5.1%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	70.2%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$27.84B	Share price x shares outstanding.
Enterprise value	$27.25B	Market cap + total debt - cash - short-term investments.
P/E	23.7x	Market cap / net income. Only when net income is positive.
P/S	2.67x	Market cap / revenue.
P/B	8.51x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	9.63x	Market cap / tangible book value, when positive.
P/FCF	17.7x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	15.0x	Market cap / cash from operations, when positive.
EV/Sales	2.62x	Enterprise value / revenue.
EV/EBIT	16.4x	Enterprise value / operating income, when both are positive.
EV/EBITDA	13.0x	Enterprise value / EBITDA, when both are positive.
EV/FCF	17.3x	Enterprise value / free cash flow, when both are positive.
FCF yield	5.6%	Free cash flow / market cap.
Earnings yield	4.2%	Net income / market cap (the inverse of P/E).
Dividend yield	0.3%	Dividends paid over the period / market cap.
Shareholder yield	4.3%	(Dividends paid + share buybacks) / market cap.

What was TechnipFMC plc's revenue in fiscal 2025?

TechnipFMC plc reported revenue of $9.93B for fiscal 2025, 9.4% higher than the year before.

Was TechnipFMC plc profitable in fiscal 2025?

Yes. Net income was $963.9M, a net margin of 9.7%.

How much free cash flow did TechnipFMC plc generate in fiscal 2025?

Cash from operations of $1.76B minus capital expenditures of $317.2M left free cash flow of $1.45B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to TechnipFMC plc